CNBC 快讯 4月19日 22:38 礼来收购Kelonia：生物科技并购密集期的风险溢价重定价机会 Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain mileston… FG 100 读报告 →